Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people

Diabetes

Volumn 57, Issue 7, 2008, Pages 1905-1917

  Rossetti, Paolo ^a   Porcellati, Francesca ^a   Ricci, Natalia Busciantella ^a   Candeloro, Paola ^a   Cioli, Patrizia ^a   Sreekumaran Nair, K ^b   Santeusanio, Fausto ^a   Bolli, Geremia B ^a   Fanelli, Carmine G ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ALANINE; AMINO ACID MIXTURE; ARGININE; ASPARTIC ACID; CYSTEINE; GLUCAGON; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HISTIDINE; HORMONE; INSULIN; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PLACEBO; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE; ADRENALIN; AMINO ACID; ANTIDIABETIC AGENT; C PEPTIDE; HYDROCORTISONE; NORADRENALIN; PANCREAS POLYPEPTIDE;

ADD ON THERAPY; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; DIABETIC PATIENT; DIGIT SPAN FORWARD TEST; DRUG EFFECT; DRUG RESPONSE; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PASED AUDITORY SERIAL ADDITION TEST; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SCREENING TEST; SINGLE DRUG DOSE; STROOP COLORED WORDS TEST; VERBAL MEMORY; AREA UNDER THE CURVE; BLOOD; CHEMICALLY INDUCED DISORDER; GENETICS; GLUCOSE CLAMP TECHNIQUE; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REFERENCE VALUE;

ADMINISTRATION, ORAL; ADULT; AMINO ACIDS; AREA UNDER CURVE; BLOOD GLUCOSE; C-PEPTIDE; COGNITION; DIABETES MELLITUS, TYPE 1; EPINEPHRINE; FEMALE; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYDROCORTISONE; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; NOREPINEPHRINE; PANCREATIC POLYPEPTIDE; QUESTIONNAIRES; REFERENCE VALUES; TRAIL MAKING TEST;

EID: 48249138555     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0276     Document Type: Article

References (47)

1. Gerich J, Langlois M, Noacco C, Karam J, Forsham P: Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha-cell defect. Science 182:171, 1973
2. Bolli G, de Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P, Gerich JE: Abnormal glucose counterregulation in insulin-dependent diabetes mellitus: interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 32:134-141, 1983
3. Bolli GB, Fanelli CG: Physiology of glucose counterregulation to hypoglycemia. In Hypoglycemic Disorders: Endocrinology and Metabolism Clinics of North America. Vol. 28. Service FJ, Ed. W.B. Saunders, Philadelphia, 1999, p. 467-493
4. Cryer PE: Hypoglycemia: the limiting factor in the management of IDDM. Diabetes 43:1378-1389, 1994
5. White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV: Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 308:485-491, 1983
6. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
7. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Di Vincenzo A, Modarelli F, Ciofetta M, Lepore M, Annibale B, Torlone E, Perriello G, De Feo P, Santeusanio F, Brunetti P, Bolli GB: Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia 37:1265-1276, 1994
8. Bolli GB: How to ameliorate the problem of hypoglycemia in intensive as well as non-intensive treatment of type 1 diabetes mellitus. Diabetes Care 22 (Suppl. 2):B43-B52, 1999
9. Rossetti P, Porcellati F, Bolli GB, Fanelli CG: Prevention of hypoglycemia while achievinggood glycemic control in type 1 diabetes mellitus: the role of insulin analogs. Diabetes Care 31 (Suppl. 2):S113-S120, 2008
10. Kuhara T, Ikeda S, Ohneda A, Sasaki Y: Effects of intravenous infusion of 17 amino acids on the secretion of Gh, glucagon and insulin in sheep. Am J Physiol 260:E21-E26, 1991
11. Caprio S, Tamborlane WV, Zych K, Gerow K, Sherwin RS: Loss of potentiating effect of hypoglycemia on the glucagon response to hyperami-noacidemia in IDDM. Diabetes 42:550-555, 1993
12. M'bemba J, Cynober L, de Bandt P, Taverna M, Chevalier A, Bardin C, Slama G, Selam JL: Effects of dipeptide administration on hypoglycaemic counterregulation in type 1 diabetes. Diabete Metab 29:412-417, 2003
13. Porcellati F, Pampanelli S, Rossetti P, Busciantella Ricci N, Marzotti S, Lucidi P, Santeusanio F, Bolli GB, Fanelli CG: Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia. Diabetologia 50:422-430, 2007
14. Fanelli CG, Pampanelli S, Porcellati F, Bartocci L, Scionti L, Rossetti P, Bolli GB: Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in type I diabetes mellitus in the postprandial state. Diabetologia 46:53-64, 2003
15. Porcellati F, Pampanelli S, Rossetti P, Cordoni C, Marzotti S, Scionti L, Bolli GB, Fanelli CG: Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans. Diabetes 52:2774-2783, 2003
16. Wiethop BV, Cryer PE: Alanine and terbutaline in treatment of hypoglycemia in IDDM. Diabetes Care 16:1131-1136, 1993
17. Wiethop BV, Cryer PE: Glycemic actions of alanine and terbutaline in IDDM. Diabetes Care 16:1124-1130, 1993
18. Evans ML, Hopkins D, Macdonald IA, Amiel SA: Alanine infusion during hypoglycaemia partly supports cognitive performance in healthy huma subjects. Diabet Med 21:440-446, 2004
19. Maran A, Cranston I, Lomas J, Macdonald I, Amiel SA: Protection by lactate of cerebral function during hypoglycaemia. Lancet 343:16-20, 1994
20. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J: Effect of hyperk-etonemia and hyperlacticacidemia on symptoms, cognitive dysfunction, and counterregulatory hormone responses during hypoglycemia in normal humans. Diabetes 43:1311-1317, 1994
21. Ewing DJ, Clarke BF: Autonomic neuropathy: its diagnosis and prognosis. Clin Endocrinol Metab 15:855-888, 1986
22. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P, Porcellati F, Scionti L, Santeusanio F, Brunetti P, Bolli GB: Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 42:1683-1689, 1993
23. McGuire E, Helderman J, Tobin J, Andres R, Berman M: Effects of arterial venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565-573, 1976
24. De Feo P, Perriello G, Ventura MM, Calcinaro F, Basta G, Lolli C, Cruciani C, Dell'Olio A, Santeusanio F, Brunetti P, Bolli GB: Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon. Diabetologia 29:475-480, 1986
25. Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, Durrant J, Cryer P, Gerich J: Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 260:E67-E74, 1991
26. Cryer PE: Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness. Endocrinol Metab Clin North Am 28:495-500, 1999
27. Boll T, Barth J: Neuropsychology of Brain Damage. In Handbook of Clinical Neuropsychology. Filskov S, Boll T, Eds. New York, Wiley, 1981, p. 418-452
28. Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS: Neuropsychological Assessment. 4th ed. New York, Oxford University Press, 2004, p. 429 -550
29. Wechsler D: Manual of the Wechsler Adult Intelligence Scale-Revised. New York, The Psychological Corporation Limited, 1981
30. Golden C: Stroop Color and Word Test. Chicago, Stoelting, 1978
31. Gronwall DMA: Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 44:367-373, 1977
32. Fanelli CG, De Feo P, Porcellati F, Perriello G, Torlone E, Santeusanio F, Brunetti P, Bolli GB: Adreneric mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. J Clin Invest 89:2005-2013, 1992
33. Nair KS, Welle SL, Tito J: Effect of plasma amino acid replacement on glucagon and substrate responses to insulin-induced hypoglycemia in humans. Diabetes 39:376-382, 1990
34. Kuzuya H, Blix PN, Horwitz DL, Steiner DF, Rubenstein AH: Determination offree and total insulin and C-peptide in insulin treated diabetics. Diabetes 26:22-29, 1977
35. Winer BJ, Brown DR, Michels KM: Statistical Principles in Experimental Design. 3rd ed. New York, McGraw-Hill, 1991, p. 497-582
36. Holland BS, Copenhaver M: Improved Bonferroni type multiple testing procedures. Psychol Bull 104:145-148, 1988
37. Iversen J: Secretion of glucagon from the isolated, perfused canine pancreas. J Clin Invest 50:2123-2136, 1971
38. Dunning BE, Foley JE, Ahrén B: Alpha cell function in health and disease: influence of glucagon-like peptide-1. Diabetologia 48:1700-1713, 2005
39. Raju B, Cryer PE: Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin deficient diabetes. Diabetes 54:757-764, 2005
40. Banarer S, McGregor VP, Cryer PE: Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes 51:958-965, 2002
41. Krarup T, Schwartz TW, Hilsted J, Madsbad S, Overlaege O, Sestoft L: Impaired response of pancreatic polypeptide to hypoglycaemia: an early sign of autonomic neuropathy in diabetics. Br Med J 2:1544-1546, 1976
42. Gold AE, MacLeod KM, Frier BM: Frequency of severe hypoglycemia in patients with type 1 diabetes with impaired awareness of hypoglycemia. Diabetes Care 17:697-703, 1994
43. Wong KL, Tyce GM: Glucose and amino acid metabolism in rat brain during sustained hypoglycemia. Neurochem Res 8:401-415, 1983
44. Lubow JM, Piñón IG, Avogaro A, Cobelli C, Treeson DM, Mandeville KA, Toffolo G, Boyle PJ: Brain oxygen utilization is unchanged by hypoglycemia in normal humans: lactate, alanine, and leucine uptake are not sufficient to offset energy deficit. Am, J Physiol Endocrinol Metab 290: E149-E153, 2006
45. Wahren J, Ekberg K, Fernqvist-Forbes E, Nair S: Brain substrate utilisation during acute hypoglycaemia. Diabetologia 42:812-818, 1999
46. Betz AL, Goldstein GW, Katzman R: Blood-brain-cerebrospinal fluid barriers. In Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. 5th ed, Siegel GJ, Ed. New York, Raven Press, 1994, p. 681-698
47. Lieberman HR: Nutrition, brain function and cognitive performance. Appetite 40:245-254, 2003